Methods for treating schizophrenia
- 专利权人:
- Ahmed Elkashef
- 发明人:
- Ahmed Elkashef
- 申请号：
- US12136099
- 公开号：
- US08247438B2
- 申请日:
- 2008.06.10
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- Treatment of schizophrenia or humans suffering from conditions associated with high dopamine levels in ventral striatum or caudate nucleus administers the compound (2S)-2-{3-[3-({[(2R,4R)-4-tert-Butoxycarbonyl-2-(2-fluorophenyl)]-3-thiazolidinyl}carbonylmethyl)ureido]phenyl}propionic acid and its physiological acceptable salts.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- compound, gaba-at activity modulation method, dopamine level modulation method, substance dependence treatment method, ornithine aminotransferase activity modulation method, ornithine aminotransferase activity reduction method expressed by a human hepatocellular carcinoma and method for treating psychological and neurological disorders
- (S) -2-N-propylamino-5-hydroxytetralin as a D3 agonistic therapeutic
- (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
- COMPOSIÇÕES PARA ADMINISTRAÇÃO CONTÍNUA DE INIBIDORES DE DOPA DECARBOXILASE
- (S)-2-N-PROPYLAMINO-5-HYDROXYTETRALINE UTILISEE COMME AGENT THERAPEUTIQUE AYANT UN EFFET AGONISTE SUR LE RECEPTEUR D3
